Abstract
A number of epidermal growth factor receptor (EGFR) deletion mutants have been identified in gliomas, in which the EGFR gene is frequently amplified and rearranged. We have previously characterized the structure of a gene in A-172 human glioma cells that encodes a 190-kDa EGFR mutant with tandem duplication of the tyrosine kinase (TK) and calcium-mediated internalization (CAIN) domains. Here we describe a 185-kDa tandem duplication mutant (TDM) that is expressed in KE and A-1235 glioma cells, along with certain functional characteristics of the mutants. The corresponding transcripts in KE and A-1235 cells contain 1053 additional nucleotides representing an in-frame duplication of exons 18 through 25 which encode the entire TK region and a portion of the CAIN domain. As with duplication of the entire TK/CAIN region (exons 18–26) in A-172 cells, duplication of exons 18–25 is associated with a specific genomic rearrangement between flanking introns. Involved introns contain homology to recombination signal sequence (RSS) heptamers present in the V(D)J region of the T lymphocyte receptor gene. In defined medium, both oncogenic TDM are constitutively autophosphorylated and inefficiently downregulated. High-affinity binding is reduced in EGFR.TDM/18–26, although the t½ of receptor internalization is not prolonged.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout









Similar content being viewed by others
References
Batra SK, Castelino-Prabhu S, Wikstrand CJ, Zhu X, Humphrey PA, Friedman HS and Bigner DD. . 1995 Cell Growth Diff. 6: 1251–1259.
Bigner SH, Humphrey PA, Wong AJ, Vogelstein B, Mark J, Friedman HS and Bigner DD. . 1990 Cancer Res. 50: 8017–8022.
Blasband AJ, Gilligan DM, Winchell LF, Wong ST, Luetteke NC, Rogers KT and Lee DC. . 1990 Oncogene 5: 1213–1221.
Callaghan T, Anctczak M, Flickinger T, Raines M, Myers M and Kung H-J. . 1993 Oncogene 8: 2939–2948.
Chen WS, Lazar CS, Lund KA, Welsh JB, Chang CP, Walton GM, Der CJ, Wiley HS, Gill GN and Rosenfeld MG. . 1989 Cell 59: 33–43.
Chu CT, Everiss KD, Wikstrand CJ, Batra SK, Kung H-J and Bigner DD. . 1997 Biochem. J. 324: 855–861.
Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J and Aaronson SA. . 1987 Cell 51: 1063–1070.
Ekstrand AJ, James CD, Cavenee WK, Seliger B, Petterson RF and Collins VP. . 1991 Cancer Res. 51: 2164–2172.
Etienne MC, Formento JL, Lebrun-Frenay C, Gioanni J, Chatel M, Paquis P, Bernard C, Courdi A, Bensadoun RJ, Pignol JP, Francoual M, Grellier P, Frenay M and Milano G. . 1998 Clin. Cancer Res. 4: 2383–2390.
Fenstermaker RA, Ciesielski MJ and Castiglia GJ. . 1998 Oncogene 16: 3435–3443.
Frisa PS, Walter EI, Ling L, Kung H-J and Jacobberger JW. . 1996 Cell Growth Diff. 7: 223–233.
Haley JD, Hsuan JJ and Waterfield MD. . 1990 Oncogene 4: 273–283.
Huang H-J Su, Nagane M, Klingbeil K, Lin H, Nishikawa R, Xiang-Dong J, Huang C-M, Gill GN, Wiley HS and Cavenee WK. . 1997 J. Biol. Chem. 272: 2927–2935.
Humphrey PA, Wong AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, Friedman HS, Kwatra MM, Bigner SH and Bigner DD. . 1990 Proc. Natl. Acad. Sci. USA 87: 4207–4211.
Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD and Bigner SH. . 1988 Cancer Res. 48: 2231–2238.
Humphrey PA, Gangarosa LM, Wong AJ, Archer GE, Lund-Johansen M, Bjerkvig R, Laerum O-D, Friedman HS and Bigner DD. . 1991 Biochem. Res. Comm. 178: 1413–1420.
Lehvaslaiho J, Lehtola L, Sistonen L and Alitalo KA. . 1989 EMBO J. 8: 159–166.
Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A and Schlessinger J. . 1985 Nature (London) 313: 144–147.
Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner D and Laerum O-D. . 1990 Cancer Res. 50: 6039–6044.
Maruno M, Kovach JS, Kelly PJ and Yanagihara T. . 1991 J. Neurosurg. 75: 97–102.
Montgomery RB, Moscatello DK, Wong AJ, Cooper JA and Stahl WL. . 1995 J. Biol. Chem. 270: 30562–30566.
Moscatello DK, Montgomery RB, Sundareshan P, McDanel H, Wong MY and Wong AJ. . 1996 Oncogene 13: 85–96.
Munson PJ and Rodbard D. . 1980 Anal. Biochem. 107: 220–239.
Nagane M, Coufal F, Lin H, Bogler O, Cavenee WK and Huang H-J. . 1996 Cancer Res. 56: 5079–5086.
Nagane M, Levitzki A, Gazit A, Cavenee WK and Huang HJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 5724–5729.
Nishikawa R, Xiang-Dong J, Harmon RC, Lazar CS, Gill GN, Cavenee WK and Huang HJ. . 1994 Proc. Natl. Acad. Sci. USA 91: 7727–7731.
O'Rourke DM, Qian X, Zhang H-T, Davis JG, Nute E, Meinkoth J and Greene MI. . 1997 Proc. Natl. Acad. Sci. USA 94: 3250–3255.
Panneerselvam K, Kanakaraj P, Raj S, Das M and Bishayee S. . 1995 Eur. J. Biochem. 230: 951–957.
Prywes R, Livneh E, Ullrich A and Schlessinger J. . 1986 EMBO J. 5: 2179–2190.
Roth DB and Craig NL. . 1998 Cell 94: 411–414.
Schlegel J, Merdes A, Stumm G, Albert FK, Forsting M, Hynes N and Kiessling M. . 1994 Int. J. Cancer 56: 72–77.
Steck PA, Lee P, Hung M-C and Yung WKA. . 1988 Cancer Res. 48: 5433–5439.
Sugawa N, Ekstrand AJ, James CD and Collins VP. . 1990 Proc. Natl. Acad. Sci. USA 87: 8602–8606.
Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Liberman TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD and Seeburg PH. . 1984 Nature (London) 309: 418–425.
Wells A, Welsh JB, Lazar CS, Wiley HS, Gill GN and Rosenfield MG. . 1990 Science 247: 962–964.
Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR and Vogelstein B. . 1987 Proc. Natl. Acad. Sci. USA 84: 6899–6903.
Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS and Vogelstein B. . 1992 Proc. Natl. Acad. Sci. USA 89: 2965–2969.
Acknowledgements
This project was supported by NIH grant CA 16056-22, The Troup Foundation and the Jeffrey Wright Fund.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ciesielski, M., Fenstermaker, R. Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function. Oncogene 19, 810–820 (2000). https://doi.org/10.1038/sj.onc.1203409
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1203409
Keywords
This article is cited by
-
CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data
Genome Biology (2020)
-
Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma
Molecular Biology Reports (2020)
-
Proteins with calmodulin-like domains: structures and functional roles
Cellular and Molecular Life Sciences (2019)
-
Gastrin-Releasing Peptide Receptor Knockdown Induces Senescence in Glioblastoma Cells
Molecular Neurobiology (2017)
-
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
Nature Genetics (2013)


